P&S Market Research - Производители товаров и услуг

The global female fertility and pregnancy rapid test market is expected to grow at a Cagr of 4.5% during the period 2016 - 2022. The global market is increasing, due to growing female geriatric population and increasing incidence of uterine malformations. In addition, the growing female infertility cases, increasing cases with abnormal uterine bleeding and growing demand for easy to use at home diagnostic devices are encouraging the growth of the global female fertility and pregnancy rapid test market. The increasing aging population is propelling the growth of the global female fertility and pregnancy rapid test market, as the elderly population is more susceptible to gynaecological problems, such as abnormal uterine bleeding, fibroids, and polyps, as compared to adults, which is fuelling the demand female fertility and pregnancy rapid tests. Aging leads to changes in hormones leading to irregular menses, which contribute to the...

The global neurostimulation device market was valued at $5,656.1 million in 2015, and it is expected to grow at a Cagr of 12.9% during the period 2016 - 2022. The neurostimulation device market is growing, due to increasing geriatric population, increasing prevalence of chronic pain, and increasing incidents of neurological disorders. In addition, the awareness about mental diseases and their treatment is also increasing across the globe. Among the different types of neurostimulation devices, the implantable/interna neurostimulation segment is expected to witness the faster growth during the forecast period. Among the various applications, the pain management segment held the largest share in the global neurostimulation device market in 2015, and it is expected to witness the fastest growth during the forecast period. The prevalence of chronic pain and neurological disorders is increasing globally, due to which the demand for better...

According to P&S Market Research, the global insulin delivery device market was valued at $9,998.3 million in 2015, and it is expected to grow at a Cagr of 6.6% during 2016-2022. Based on type, the insulin pump segment is expected to witness the fastest growth at a Cagr of 7.2% during the forecast period. The global insulin delivery device market is growing at a significant rate, due to increasing prevalence of diabetes and growing geriatric population. The increasing prevalence of obesity, technological advancement in delivery devices and increasing awareness about diabetic care are also driving the growth of the global insulin delivery device market. However, the factors such as high cost of analogue and hazards and risks associated with drug delivery devices are inhibiting the growth of the global market. Diabetes is a chronic disease caused, due to insufficient production or inappropriate use of insulin in the body. It is a...